Julie Errington
- Molecular Biology
- Oncology
- Pediatrics, Perinatology and Child Health top 10%
- Neurology top 10%
- Public Health, Environmental and Occupational Health
- Co-authors
- Gareth J. VealAlan V. BoddyAndrew D.J. PearsonMichael ColeDavid R. NewellXiaohong LüNicola J. CurtinJohn Lunec
- Topics
- Neuroblastoma Research and Treatments (10 papers)Cancer therapeutics and mechanisms (9 papers)Childhood Cancer Survivors' Quality of Life (5 papers)
- Partner nations
- United KingdomAustraliaIndia
In The Last Decade
Julie Errington
24 papers receiving 564 citations
Peers
Comparison fields: 5 of 85
- Molecular Biology 303
- Oncology 158
- Pediatrics, Perinatology and Child Health 109
- Neurology 103
- Public Health, Environmental and Occupational Health 85
Countries citing papers authored by Julie Errington
This map shows the geographic impact of Julie Errington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Errington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Errington more than expected).
Fields of papers citing papers by Julie Errington
This network shows the impact of papers produced by Julie Errington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Errington. The network helps show where Julie Errington may publish in the future.
Co-authorship network of co-authors of Julie Errington
This figure shows the co-authorship network connecting the top 25 collaborators of Julie Errington. A scholar is included among the top collaborators of Julie Errington based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Errington. Julie Errington is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 26 | |
| 2 | 21 | |
| 3 | 8 | |
| 4 | 15 | |
| 5 | 50 | |
| 6 | 4 | |
| 7 | 30 | |
| 8 | 0 | |
| 9 | 36 | |
| 10 | 38 | |
| 11 | 20 | |
| 12 | 15 | |
| 13 | 14 | |
| 14 | 32 | |
| 15 | 42 | |
| 16 | 6 | |
| 17 | A study to investigate the pharmacokinetics of carboplatin and etoposide in infants with neuroblastoma | 2 |
| 18 | 19 | |
| 19 | 28 | |
| 20 | Cellular ATP depletion by LY309887 as a predictor of growth inhibition in human tumor cell lines. | 29 |
About Julie Errington
Julie Errington is a scholar working on Neurology, Pediatrics, Perinatology and Child Health and Ophthalmology, having authored 25 papers that have together received 573 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (10 papers), Cancer therapeutics and mechanisms (9 papers) and Childhood Cancer Survivors' Quality of Life (5 papers). The work is most often cited by research in Neurology (103 citations), Oncology (158 citations) and Pediatrics, Perinatology and Child Health (109 citations). Julie Errington has collaborated with scholars based in United Kingdom, Australia and India. Frequent co-authors include Gareth J. Veal, Alan V. Boddy, Andrew D.J. Pearson, Michael Cole, David R. Newell, Xiaohong Lü, Nicola J. Curtin, John Lunec, Christopher Hill and A.B.M. Foot. Their work appears in journals such as Cancer Research, Clinical Cancer Research and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.